Trial Profile
Kebele Elimination of Trachoma for Ocular Health
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Feb 2023
Price :
$35
*
At a glance
- Drugs Azithromycin (Primary)
- Indications Trachoma
- Focus Therapeutic Use
- Acronyms KETFO
- 22 Feb 2022 Planned End Date changed from 1 Dec 2027 to 1 Mar 2028.
- 22 Feb 2022 Planned primary completion date changed from 1 Dec 2026 to 1 Mar 2027.
- 22 Feb 2022 Status changed from not yet recruiting to recruiting.